See today's BioWorld
To read the full article sign up for free or sign in.

Providence and Everest’s vaccine is first mRNA in WHO’s Solidarity Trial Vaccines study

Dec. 20, 2021
By David Ho
Everest Medicines Ltd. and Providence Therapeutics Holdings Inc.’s COVID-19 vaccine was cleared for inclusion in the World Health Organization’s (WHO) Solidarity Trial Vaccines clinical trial.  
BioWorld Clinical Coronavirus Vaccine Asia-Pacific WHO